Tonix Pharmaceuticals
TNXP • NASDAQ
Tonix Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Seth Lederman, with a market cap of $191.9M.
Market Cap$191.9M
Employees103.0
CEOSeth Lederman
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Tonix Pharmaceuticals FAQ
Common questions about Tonix Pharmaceuticals
Tonix Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 11, 2026 before market open. Analysts estimate revenue of $5.3M.
Tonix Pharmaceuticals has approximately 103 employees.